DOI QR코드

DOI QR Code

Factors Influencing Age-Related Loss of Skeletal Muscle Mass in Young Korean Men

  • Jongseok Hwang (Institute of Human Ecology, Yeungnam University) ;
  • Jeong-Kun Lee (Department of Orthopedic Surgery, School of Medicine, Konkuk University)
  • Received : 2023.11.09
  • Accepted : 2023.11.16
  • Published : 2023.11.30

Abstract

PURPOSE: This study aimed to identify the clinical factors that contribute to age-related loss of skeletal muscle mass (ALSMM) among young Korean male adults. METHODS: This was a cross-sectional study involving 955 men aged between 20-29 years. They underwent screening to assess the ALSMM. The study examined a variety of factors, including age, height, weight, body mass index (BMI), waist circumference (WC), skeletal muscle mass index (SMI), lifestyle-related habits such as smoking and drinking status, systolic and diastolic blood pressure (SBP/DBP), fasting blood glucose (FBG) levels, as well as the serum triglyceride and total cholesterol (TC) levels. RESULTS: The variables that displayed significant associations with ALSMM were height, weight, BMI, WC, SMI, FBG, TC, DBP, and alcohol consumption (p < .05). Serum triglyceride levels, SBP, and smoking status did not exhibit statistical significance (p > .05). CONCLUSION: The study identified the contributing factors associated with the ALSMM in community-dwelling young adult males. These findings would enrich the current body of literature on ALSMM and provide potential risk factors associated with its development in young Korean males.

Keywords

References

  1. Rosenberg IH. Sarcopenia: origins and clinical relevance. J Nutr. 1997;127(5 Suppl):990S-1S.  https://doi.org/10.1093/jn/127.5.990S
  2. Kulik CT, Ryan S, Harper S, et al. Aging populations and management. Academy of Management Briarcliff Manor, NY. 2014. pp.929-35. 
  3. Liu X, Hao Q, Yue J, et al. Sarcopenia, Obesity and Sarcopenia Obesity in Comparison: Prevalence, Metabolic Profile, and Key Differences: Results from WCHAT Study. J Nutr Health Aging. 2020;24(4):429-37.  https://doi.org/10.1007/s12603-020-1332-5
  4. Brown JC, Harhay MO, Harhay MN. Sarcopenia and mortality among a population-based sample of community-dwelling older adults. J Cachexia Sarcopenia Muscle. 2016;7(3):290-8.  https://doi.org/10.1002/jcsm.12073
  5. Hai S, Wang H, Cao L, et al. Association between sarcopenia with lifestyle and family function among community-dwelling Chinese aged 60 years and older. BMC Geriatr. 2017;17(1):187. 
  6. Chan R, Leung J, Woo J. A Prospective Cohort Study to Examine the Association Between Dietary Patterns and Sarcopenia in Chinese Community-Dwelling Older People in Hong Kong. J Am Med Dir Assoc. 2016;17(4):336-42.  https://doi.org/10.1016/j.jamda.2015.12.004
  7. Hwang J, Park S. Sex Differences of Sarcopenia in an Elderly Asian Population: The Prevalence and Risk Factors. International Journal of Environmental Research and Public Health. 2022;19(19):11980. 
  8. Nishiguchi S, Yamada M, Fukutani N, et al. Differential association of frailty with cognitive decline and sarcopenia in community-dwelling older adults. J Am Med Dir Assoc. 2015;16(2):120-4.  https://doi.org/10.1016/j.jamda.2014.07.010
  9. Kang SY, Lim GE, Kim YK, et al. Association between Sarcopenic Obesity and Metabolic Syndrome in Postmenopausal Women: A Cross-sectional Study Based on the Korean National Health and Nutritional Examination Surveys from 2008 to 2011. J Bone Metab. 2017;24(1):9-14.  https://doi.org/10.11005/jbm.2017.24.1.9
  10. Velazquez-Alva MC, Irigoyen Camacho ME, Lazarevich I, et al. Comparison of the prevalence of sarcopenia using skeletal muscle mass index and calf circumference applying the European consensus definition in elderly Mexican women. Geriatr Gerontol Int. 2017;17(1):161-70.  https://doi.org/10.1111/ggi.12652
  11. Lee HN KB. Convergence Factors Affecting Sarcopenia in Middle-Aged and Older Women in Korea: A Cross Sectional Study by Using 5th KNHANES. Journ Kor Converg Soc. 2020;11(11):405-16. 
  12. Hwang J, Park S. Gender-Specific Risk Factors and Prevalence for Sarcopenia among Community-Dwelling Young-Old Adults. International Journal of Environmental Research and Public Health. 2022;19(12):7232. 
  13. Hwang J. Unraveling the Contributing Factors of Sarcopenia in Young Korean Male Adults: A Study of Occurrence, Somatometric, Biochemical, and Behavioral Characteristics. J Korean Soc Phys Med. 2023;18(3):21-30.  https://doi.org/10.13066/kspm.2023.18.3.21
  14. Hwang J. Comprehensive Investigation on the Prevalence and Risk Factors of Coexistence of Age-related Loss of Skeletal Muscle Mass and Obesity among Males in Their 40s. J Korean Soc Phys Med. 2023;18(3):1-9.  https://doi.org/10.13066/kspm.2023.18.3.1
  15. Hwang J. Age-Related Loss of Skeletal Muscle and Associated Risk Factors in Middle-Aged Men: A Comprehensive Study. J Korean Soc Phys Med. 2023;18(2):13-21.  https://doi.org/10.13066/kspm.2023.18.2.13
  16. Hwang J. Prevalence, Anthropometric Risk Factors, and Clinical Risk Factors in Sarcopenic Women in Their 40s. J Korean Soc Phys Med. 2023;18(2):23-31.  https://doi.org/10.3346/jkms.2003.18.1.23
  17. Hwang J, Moon IY. Exploring incidence and potential risk factors of sarcopenic obesity among middle-aged women residing in a community. J Korean Soc Phys Med. 2023;18(3):11-9.  https://doi.org/10.13066/kspm.2023.18.3.11
  18. Hwang J, Park S. A Korean Nationwide Cross-Sectional Study Investigating Risk Factors, Prevalence, and Characteristics of Sarcopenia in Men in Early Old Age. Healthcare. MDPI. 2023. pp.2860. 
  19. Hwang J, Park S. Gender-Specific Prevalence and Risk Factors of Sarcopenic Obesity in the Korean Elderly Population: A Nationwide Cross-Sectional Study. International Journal of Environmental Research and Public Health. 2023;20(2):1140. 
  20. Studenski SA, Peters KW, Alley DE, et al. The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates. J Gerontol A Biol Sci Med Sci. 2014;69(5):547-58.  https://doi.org/10.1093/gerona/glu010
  21. Sanada K, Miyachi M, Tanimoto M, et al. A cross-sectional study of sarcopenia in Japanese men and women: reference values and association with cardiovascular risk factors. Eur J Appl Physiol. 2010;110(1):57-65.  https://doi.org/10.1007/s00421-010-1473-z
  22. Confortin SC, Meneghini V, Ono LM, et al. Anthropometric indicators as a screening tool for sarcopenia in older adults from Florianopolis, Santa Catarina: EpiFloripa Ageing study. Revista De Nutricao-Brazilian Journal of Nutrition. 2017;30(3): 287-96.  https://doi.org/10.1590/1678-98652017000300002
  23. Zamboni M, Mazzali G, Fantin F, et al. Sarcopenic obesity: a new category of obesity in the elderly. Nutr Metab Cardiovasc Dis. 2008;18(5):388-95.  https://doi.org/10.1016/j.numecd.2007.10.002
  24. Nair KS. Aging muscle. Am J Clin Nutr. 2005;81(5):953-63.  https://doi.org/10.1093/ajcn/81.5.953
  25. Tilg H, Moschen AR. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol. 2006;6(10):772-83.  https://doi.org/10.1038/nri1937
  26. Cesari M, Kritchevsky SB, Baumgartner RN, et al. Sarcopenia, obesity, and inflammation--results from the Trial of Angiotensin Converting Enzyme Inhibition and Novel Cardiovascular Risk Factors study. Am J Clin Nutr. 2005;82(2):428-34.  https://doi.org/10.1093/ajcn/82.2.428
  27. Lu CW, Yang KC, Chang HH, et al. Sarcopenic obesity is closely associated with metabolic syndrome. Obes Res Clin Pract. 2013;7(4):e301-7.  https://doi.org/10.1016/j.orcp.2012.02.003
  28. Abidin Ozturk ZA, Turkbeyler IH, Demir Z, et al. The effect of blood glucose regulation on sarcopenia parameters in obese and diabetic patients. Turk J Phys Med Rehabil. 2018;64(1):72-9.  https://doi.org/10.5606/tftrd.2018.1068
  29. Du Y, Oh C, No J. Associations between Sarcopenia and Metabolic Risk Factors: A Systematic Review and Meta-Analysis. J Obes Metab Syndr. 2018;27(3):175-85.  https://doi.org/10.7570/jomes.2018.27.3.175
  30. Cui M, Gang X, Wang G, et al. A cross-sectional study: Associations between sarcopenia and clinical characteristics of patients with type 2 diabetes. Medicine (Baltimore). 2020;99(2):e18708. 
  31. Buscemi C, Ferro Y, Pujia R, et al. Sarcopenia and Appendicular Muscle Mass as Predictors of Impaired Fasting Glucose/Type 2 Diabetes in Elderly Women. Nutrients. 2021;13(6):1909. 
  32. Janssen I, Heymsfield SB, Wang ZM, et al. Skeletal muscle mass and distribution in 468 men and women aged 18-88 yr. J Appl Physiol (1985). 2000;89(1):81-8.  https://doi.org/10.1152/jappl.2000.89.1.81
  33. Lundsgaard AM, Kiens B. Gender differences in skeletal muscle substrate metabolism - molecular mechanisms and insulin sensitivity. Front Endocrinol (Lausanne). 2014;5:195. 
  34. Du Y, Wang X, Xie H, et al. Sex differences in the prevalence and adverse outcomes of sarcopenia and sarcopenic obesity in community dwelling elderly in East China using the AWGS criteria. BMC Endocr Disord. 2019;19(1):109. 
  35. Cleasby ME, Jamieson PM, Atherton PJ. Insulin resistance and sarcopenia: mechanistic links between common co-morbidities. J Endocrinol. 2016;229(2):R67-81.  https://doi.org/10.1530/JOE-15-0533
  36. Schrager MA, Metter EJ, Simonsick E, et al. Sarcopenic obesity and inflammation in the InCHIANTI study. J Appl Physiol (1985). 2007;102(3):919-25.  https://doi.org/10.1152/japplphysiol.00627.2006
  37. Daskalopoulou C, Wu YT, Pan W, et al. Factors related with sarcopenia and sarcopenic obesity among low- and middle-income settings: the 10/66 DRG study. Sci Rep. 2020;10(1):20453. 
  38. Pang BWJ, Wee SL, Lau LK, et al. Prevalence and Associated Factors of Sarcopenia in Singaporean Adults-The Yishun Study. J Am Med Dir Assoc. 2021;22(4):885 e1-e10. 
  39. Cui YF, Huang C, Momma H, et al. The longitudinal association between alcohol consumption and muscle strength: A population-based prospective study. Journal of Musculoskeletal & Neuronal Interactions. 2019;19(3):294-9. 
  40. Jyothi MS, Reddy KR, Soontarapa K, et al. Membranes for dehydration of alcohols via pervaporation. J Environ Manage. 2019;242:415-29.  https://doi.org/10.1016/j.jenvman.2019.04.043
  41. Atkins JL, Whincup PH, Morris RW, et al. Sarcopenic obesity and risk of cardiovascular disease and mortality: a population-based cohort study of older men. J Am Geriatr Soc. 2014;62(2):253-60.  https://doi.org/10.1111/jgs.12652
  42. Androga L, Sharma D, Amodu A, et al. Sarcopenia, obesity, and mortality in US adults with and without chronic kidney disease. Kidney Int Rep. 2017;2(2):201-11.  https://doi.org/10.1016/j.ekir.2016.10.008
  43. Yin T, Zhang JX, Wang FX, et al. The Association Between Sarcopenic Obesity and Hypertension, Diabetes, and Abnormal Lipid Metabolism in Chinese Adults. Diabetes Metab Syndr Obes. 2021;14:1963-73.  https://doi.org/10.2147/DMSO.S308387
  44. Ferreira I, Snijder MB, Twisk JW, et al. Central fat mass versus peripheral fat and lean mass: opposite (adverse versus favorable) associations with arterial stiffness? The Amsterdam Growth and Health Longitudinal Study. J Clin Endocrinol Metab. 2004;89(6):2632-9.  https://doi.org/10.1210/jc.2003-031619
  45. Snijder MB, Henry RM, Visser M, et al. Regional body composition as a determinant of arterial stiffness in the elderly: The Hoorn Study. J Hypertens. 2004;22(12):2339-47.  https://doi.org/10.1097/00004872-200412000-00016
  46. Dominguez LJ, Barbagallo M. The cardiometabolic syndrome and sarcopenic obesity in older persons. J Cardiometab Syndr. 2007;2(3):183-9.  https://doi.org/10.1111/j.1559-4564.2007.06673.x
  47. Goswami B, Reang T, Sarkar S, et al. Role of body visceral fat in hypertension and dyslipidemia among the diabetic and nondiabetic ethnic population of Tripura-A comparative study. J Family Med Prim Care. 2020;9(6):2885-90.  https://doi.org/10.4103/jfmpc.jfmpc_187_20
  48. Hashemi R, Shafiee G, Motlagh AD, et al. Sarcopenia and its associated factors in Iranian older individuals: Results of SARIR study. Arch Gerontol Geriatr. 2016;66:18-22.  https://doi.org/10.1016/j.archger.2016.04.016
  49. Therakomen V, Petchlorlian A, Lakananurak N. Prevalence and risk factors of primary sarcopenia in community-dwelling outpatient elderly: a cross-sectional study. Sci Rep. 2020;10(1):19551.